Showing 1441-1450 of 2217 results for "".
- Clear Face Masks Boost Patient Communicationhttps://modernaesthetics.com/news/clear-face-masks-boost-patient-communication/2473073/It turms out seeing really is believing. New research shows that doctors who wear transparent face masks greatly improve communication with patients compared to doctors whose faces are blocked by a standard face masks. What’s more, providers who wore the ClearMask
- Nutrafol Launches Pro-Strength Boostershttps://modernaesthetics.com/news/nutrafol-launches-pro-strength-boosters/2473071/New professional-strength boosters from Nutrafol extend the popular nutraceutical line, providing physicians the opportunity to individualize recommendations for each patient’s specific hair health needs. Hairbiotic MD is a professional-strength
- It's A Deal: Eirion Therapeutics, Shanghai Haohai Biological Technology Close $40M Series A Investment and Licensing Dealhttps://modernaesthetics.com/news/its-a-deal-eirion-therapeutics-inc-shanghai-haohai-biological-technology-closes-40m-series-a-investment-and-licensing-deal/2473070/Eirion Therapeutics, Inc. closed a $40 million Series A investment and licensing deal with Shanghai Haohai Biological Technology Ltd. The deal will result in a $32 million Series A Preferred Stock investment into Eirion along with exclusive licenses that will be for all of Eir
- Solta Rolls Out Next Generation Clear + Brilliant Laserhttps://modernaesthetics.com/news/solta-rolls-out-next-generation-clear-brilliant-laser/2473069/Solta Medical is launching Clear + Brilliant Touch laser, the company’s next generation Clear + Brilliant laser. By seamlessly switching between two wavelengths with the Original and Perméa handpieces, physicians can now more easily deliver a
- Industry Responds to COVID-19: Biopelle, Galderma US Aestheticshttps://modernaesthetics.com/news/industry-responds-to-covid-19-biopelle-galderma-us-aesthetics/2473063/Biopelle One bright spot for many aesthetic practices during the COVID-19 pandemic has been persistent and perhaps increased demand for skincare. Biopelle has responded to support physicians who wish to dispense their products. “We offer a ski
- Soliton Receives Best New Technology Awardhttps://modernaesthetics.com/news/soliton-named-best-new-technology/2473062/Soliton's Rapid Acoustic Pulse (RAP) device received the Best New Technology Award from the Aesthetic Industry Association (AIA). The Soliton RAP device, which uses proprietary design acoustic shockwaves to mechanically disrupt targeted cellular structures in a completely
- Pulse Biosciences Gets FDA Clearance for CellFXhttps://modernaesthetics.com/news/pulse-biosciences-gets-fda-clearance-for-cellfx/2473058/The FDA has cleared the CellFX® System from Pulse Biosciences, Inc. for dermatologic procedures requiring ablation and resurfacing of the skin, and a controlled commercial launch will soon beginning in the US with a of select group of leaders in aesthetic dermatology. The
- AestheticsWire Exclusive: AAFPRS Survey Shows Plastic Surgery Zoom Boom Likely Here to Stayhttps://modernaesthetics.com/news/aestheticswire-exclusive-aafprs-survey-shows-plastic-surgery-zoom-boom-likely-here-to-stay/2473056/When it comes to requests for facial plastic surgery, the Zoom Boom is real and will likely continue to keep cosmetic doctors busy for years to come, according to the 2020 statistics from the
- New Launch Alert: MERZ Introduces Belotero Balance(+) with Lidocaine in the UShttps://modernaesthetics.com/news/new-launch-alert-merz-introduces-belotero-balance-with-lidocaine-in-the-us/2473054/Merz Aesthetics is launching Belotero Balance(+) with Lidocainein the US. “Healthcare providers can now rely on the well-known rheological properties and performance of Belotero Balance with the time savings and consistency of a pre-mixed lidocaine formulation,” says Patrick
- Pulse Biosciences Receives European Clearance for CellFX Systemhttps://modernaesthetics.com/news/pulse-biosciences-receives-european-clearance-for-cellfx-system/2473050/Pulse Biosciences, Inc. will proceed with its planned controlled launch of the CellFX System to medical practices within the European Union (EU), now that it has received CE mark for the system. The European clearance is for the treatment of general dermatologic conditions, includi